Actively Recruiting
Analysis of Human ALS Tissues and Registry of ALS Patients
Led by University of Illinois at Chicago · Updated on 2025-09-22
40
Participants Needed
1
Research Sites
487 weeks
Total Duration
On this page
Sponsors
U
University of Illinois at Chicago
Lead Sponsor
T
Tanabe Pharma America, Inc.
Collaborating Sponsor
AI-Summary
What this Trial Is About
Amyotrophic Lateral Sclerosis (ALS), often referred to as Lou Gehrig's Disease, is a progressive, terminal condition of muscle weakness that is associated with degeneration of neurons in the spinal cord and brain. This devastating disorder afflicts people in the prime of their lives. At the present time, there are no cures for this disorder, and current treatments are marginal at best. Despite years of intensive research, a fundamental understanding of this disease is still lacking. There is a need to identify both reliable markers of disease progression and effective treatments. The goal of this research is to bring a greater understanding of ALS patients closer to the research studies that can lead to new hypotheses and approaches.
CONDITIONS
Official Title
Analysis of Human ALS Tissues and Registry of ALS Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients over the age of 18
- Established diagnosis of ALS
- Able and willing to give written informed consent and must authorize release and use of protected health information
You will not qualify if you...
- Patients below the age of 18
- No diagnosis of ALS
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Illinois at Chicago
Chicago, Illinois, United States, 60612
Actively Recruiting
Research Team
A
Ayo Fasawe
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here